With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

• Wall Street expects Tamboran Resources Corp. (NYSE:TBN) to post a quarterly loss of 30 cents per share on revenue of $3.82 million before the opening bell, according to data from Benzinga Pro. Tamboran Resources shares gained 1.4% to close at $36.25 on Thursday.
• Scholastic Corp. (NASDAQ:SCHL) reported downbeat results for the first quarter after the closing bell on Thursday. The company posted quarterly losses of $3.63 per share, which missed the analyst consensus estimate of losses of $3.40 per share. The company reported quarterly sales of $216.800 million, which missed the analyst consensus estimate of $224.689 million. Scholastic shares dipped 12.2% to $30.58 in the after-hours trading session.
• Costco Wholesale Corp. (NASDAQ:COST) posted better-than-expected fourth-quarter fiscal 2026 results. Costco Wholesale reported quarterly earnings of $6.75 per share, which beat the consensus estimate of $6.52. Quarterly revenue came in at $95.72 billion, which beat the Street estimate of $94.86 billion. Costco shares rose 0.2% to $898.00 in after-hours trading.

Check out our premarket coverage here

• Prime Medicine Inc. (NASDAQ:PRME) announced the FDA clearance of its Investigational New Drug application for PM647 in Alpha-1 antitrypsin deficiency. Prime Medicine shares jumped 11.7% to $3.43 in the after-hours trading session.
• INLIF Ltd. (NASDAQ:INLF) reported a 26.01% net revenue rise in its unaudited first-half fiscal 2026 results. Net revenue of $12.94 million was up from $10.27 million a year earlier. INLIF shares jumped 93.2% to $5.70 in the after-hours trading session.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.